Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9930)
All Articles published online
|
Oct 22, 2012 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatr 2012; 2(5): 74-82 [PMID: 24175171 DOI: 10.5498/wjp.v2.i5.74] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v2/i5/74.htm |
| Number | Citing Articles |
| 1 |
Anand Chukka, Soumya Choudhary, Siddharth Dutt, Ameya Bondre, Preethi Reddy, Deepak Tugnawat, Abhijit R. Rozatkar, Urvakhsh Mehta, Narayana Manjunatha, Matcheri Keshavan, Vikram Patel, Suresh Bada Math, Channaveerachari Naveen Kumar, Jagadisha Thirthalli, Anant Bhan, John Torous, John A. Naslund. Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities. Current Treatment Options in Psychiatry 2023; 10(4): 346 doi: 10.1007/s40501-023-00309-2
|
| 2 |
Heidi C. Waters, Robert Stellhorn, Maelys Touya, Heather Fitzgerald, Sandipan Bhattacharjee, Leslie Citrome. The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data. Journal of Medical Economics 2023; 26(1): 316 doi: 10.1080/13696998.2023.2178770
|
| 3 |
Emilie Leclerc, Cristiano Noto, Rodrigo A. Bressan, Elisa Brietzke. Determinants of adherence to treatment in first-episode psychosis: a comprehensive review. Revista Brasileira de Psiquiatria 2015; 37(2): 168 doi: 10.1590/1516-4446-2014-1539
|
| 4 |
Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, Juan José Fernández-Miranda. Mirror image study (10 years of follow-up and 10 of standard pre-treatment) of psychiatric hospitalizations of patients with severe schizophrenia treated in a community-based, case-managed programme. Revista de Psiquiatría y Salud Mental (English Edition) 2022; 15(1): 47 doi: 10.1016/j.rpsmen.2022.01.002
|
| 5 |
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci, Silvana Galderisi. Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.970210
|
| 6 |
Joyce Protas Mlay, Lise Jamieson, Vuyokazi Ntlantsana, Thirusha Naidu, Busisiwe Siphumelele Bhengu, Saeeda Paruk, Jonathan K Burns, Bonginkosi Chiliza, Richard Lessells, Andrew Tomita. Developing and testing unconditional cash transfer strategies among young adults with first-episode psychosis in South Africa: a study protocol for a pilot randomised control trial (PRS-FEP trial). BMJ Open 2022; 12(12): e067026 doi: 10.1136/bmjopen-2022-067026
|
| 7 |
Marwa Abdel-Rahman Sultan, Reem El Sayad Hashem, Nesreen Mohamed Mohsen, Doaa Helmy Barakat, Ramy Ali Ryad, Afaf Hamed Khalil. Studying medication adherence in patients with schizophrenia. Middle East Current Psychiatry 2016; 23(1): 27 doi: 10.1097/01.XME.0000475315.51718.d6
|
| 8 |
Christy Lai Ming Hui, Venessa Wing Yan Poon, Wai Tung Ko, Ho Yee Miao, Wing Chung Chang, Edwin Ho Ming Lee, Sherry Kit Wa Chan, Jingxia Lin, Eric Yu Hai Chen. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis. Schizophrenia Research 2016; 174(1-3): 144 doi: 10.1016/j.schres.2016.03.026
|
| 9 |
Phoebe Wallman, Ivana Clark, David Taylor. Effect of 3-monthly paliperidone palmitate on hospitalisation in a naturalistic schizophrenia cohort – A five-year mirror image study. Journal of Psychiatric Research 2022; 148: 131 doi: 10.1016/j.jpsychires.2022.01.044
|
| 10 |
Ludovic Samalin, Ingrid de Chazeron, Olivier Blanc, Lore Brunel, Guillaume Fond, Pierre-Michel Llorca. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia. Schizophrenia Research 2016; 178(1-3): 1 doi: 10.1016/j.schres.2016.09.015
|
| 11 |
Arnold P. M. van der Lee, Ibrahim Önsesveren, André I. Wierdsma, Roos van Westrhenen, Aartjan T. F. Beekman, Lieuwe de Haan, Niels C. L. Mulder. The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study. CNS Drugs 2021; doi: 10.1007/s40263-021-00802-3
|
| 12 |
S. Heres, M. Lambert, R. Vauth. Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics. European Psychiatry 2014; 29(S2): 1409 doi: 10.1016/S0924-9338(14)70001-X
|
| 13 |
Maria João R.V. Martins, Ana Margarida Pinto, Paula Castilho, António F. Macedo, Ana Telma Pereira, Miguel Bajouco, Rita Leite, Ondina Matos, Sofia Morais, Nuno Madeira, Vasco Nogueira, Carolina Roque, Prazeres Santos, Telma Santos, Tiago Santos, Vítor Santos, Ana Filipa Troia, Célia Barreto-Carvalho. Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scale. Psychiatry Research 2019; 273: 325 doi: 10.1016/j.psychres.2019.01.043
|
| 14 |
Lei Dou, Lili Hu, Nan Zhang, Henry Cutler, Yan Wang, Shunping Li. <p>Factors Associated with Medication Adherence Among Patients with Severe Mental Disorders in China: A Propensity Score Matching Study</p>. Patient Preference and Adherence 2020; : 1329 doi: 10.2147/PPA.S255934
|
| 15 |
Meaghan Roach, Dee Lin, Marlon Graf, Priti Pednekar, Jacquelyn W Chou, Carmela Benson, Jalpa A Doshi. Schizophrenia population health management: perspectives of and lessons learned from population health decision makers. Journal of Managed Care & Specialty Pharmacy 2021; 27(10-a Suppl): S2 doi: 10.18553/jmcp.2021.27.10-aa.s2
|
| 16 |
Daisy Ng-Mak, Krithika Rajagopalan. Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measures. Current Medical Research and Opinion 2019; 35(1): 87 doi: 10.1080/03007995.2018.1532883
|
| 17 |
Jiansong Zhou, Yu-Tao Xiang, Qiguang Li, Xiaomin Zhu, Wen Li, Gabor S. Ungvari, Chee H. Ng, Dost Ongur, Xiaoping Wang. Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia. Psychiatry Research 2016; 245: 276 doi: 10.1016/j.psychres.2016.08.041
|
| 18 |
Heidi Herinckx, Paula Gubrud, Alyssa Kerlinger, Karen Cellarius. Identifying Competencies of the ACT Program Nurse Using the DACUM Method. Issues in Mental Health Nursing 2024; : 1 doi: 10.1080/01612840.2024.2328255
|
| 19 |
Maria Skott, Natalie Durbeej, Maria Smitmanis-Lyle, Clara Hellner, Emelie Allenius, Sigrid Salomonsson, Tobias Lundgren, Nitya Jayaram-Lindström, Alexander Rozental. Patient-controlled admissions to inpatient care: A twelve-month naturalistic study of patients with schizophrenia spectrum diagnoses and the effects on admissions to and days in inpatient care. BMC Health Services Research 2021; 21(1) doi: 10.1186/s12913-021-06617-8
|
| 20 |
Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Lee. Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide, health insurance data-based study. BMC Psychiatry 2022; 22(1) doi: 10.1186/s12888-022-04292-5
|
| 21 |
Gloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, Emanuela Amici, Filippo Perrini, Gemma Callovini, Alfonso Carannante, Georgios D. Kotzalidis, Sergio De Filippis. Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis. Frontiers in Psychiatry 2020; 10 doi: 10.3389/fpsyt.2019.00935
|
| 22 |
Sung Woo Joo, Harin Kim, Young Tak Jo, Young Jae Choi, Soojin Ahn, Jungsun Lee. Antipsychotic treatment and risk of discontinuation and hospitalization in first-episode schizophrenia: a nationwide population-based study. Psychological Medicine 2023; 53(1): 181 doi: 10.1017/S0033291721001379
|
| 23 |
Jean-Michel Azorin, Nicolas Simon. Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationale. Expert Opinion on Drug Metabolism & Toxicology 2020; 16(12): 1175 doi: 10.1080/17425255.2020.1821646
|
| 24 |
Tim Schuster, Agnes Lowe, Karolin Weide, Daniel Kamp, Mathias Riesbeck, Andreas Bechdolf, Anke Brockhaus-Dumke, René Hurlemann, Ana Muthesius, Stefan Klingberg, Martin Hellmich, Sabine Schmied, Andreas Meyer-Lindenberg, Wolfgang Wölwer. Feasibility of six-month outpatient cognitive remediation in schizophrenia: Experience from the randomized controlled integrated social cognition and social skills therapy study. Schizophrenia Research: Cognition 2023; 33: 100285 doi: 10.1016/j.scog.2023.100285
|
| 25 |
José Manuel Olivares, Ana González-Pinto, Mario Páramo. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. European Psychiatry 2021; 64(1) doi: 10.1192/j.eurpsy.2021.23
|
| 26 |
G. Gozlan, L. Lecardeur, A.-S. Monfort, M. Doz, I. Ortiz, P. Larroumets, A. Lafuma. Analyse coût-efficacité de l’aripiprazole injectable à libération prolongée (AILP) comparé au palmitate de palipéridone (PP) dans le traitement de la schizophrénie en France. L'Encéphale 2018; 44(6): 496 doi: 10.1016/j.encep.2018.10.001
|
| 27 |
Jelena Vrublevska. Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms. Frontiers in Psychiatry 2023; 14 doi: 10.3389/fpsyt.2023.1134692
|
| 28 |
Matt A. Brown, Ram J. Bishnoi, Sara Dholakia, Dawn I. Velligan. Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials. Expert Review of Clinical Pharmacology 2016; 9(4): 591 doi: 10.1586/17512433.2016.1135734
|
| 29 |
Susanne Jaeger, Franziska Hüther, Tilman Steinert. Refusing Medication Therapy in Involuntary Inpatient Treatment—A Multiperspective Qualitative Study. Frontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00295
|
| 30 |
Julien François, Anne-Françoise Audrain-Pontevia, Sana Boudhraâ, Stéphane Vial. Assessing the Influence of Patient Empowerment Gained Through Mental Health Apps on Patient Trust in the Health Care Provider and Patient Compliance With the Recommended Treatment: Cross-sectional Study. Journal of Medical Internet Research 2024; 26: e48182 doi: 10.2196/48182
|
| 31 |
Hélène Verdoux, Clélia Quiles, Laura Bon, Isabelle Chéreau-Boudet, Julien Dubreucq, Emilie Legros-Lafarge, Nathalie Guillard-Bouhet, Catherine Massoubre, Julien Plasse, Nicolas Franck. Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers. European Archives of Psychiatry and Clinical Neuroscience 2021; 271(8): 1415 doi: 10.1007/s00406-020-01207-x
|
| 32 |
Jamilla J Giles, Ivan Ling, Nigel McArdle, Romola S Bucks, Gemma Cadby, Bhajan Singh, Vera A Morgan, Laura Gabriel, Flavie Waters. Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic Disorders. Schizophrenia Bulletin 2022; 48(2): 437 doi: 10.1093/schbul/sbab100
|
| 33 |
J. Leijala, O. Kampman, J. Suvisaari, S. Eskelinen. Association of somatic comorbidity and treatment adherence in patients with psychotic disorder. Journal of Psychiatric Research 2024; 174: 1 doi: 10.1016/j.jpsychires.2024.03.039
|
| 34 |
Jahangir Khan, Jwaad A Khan, Subhra Kumari, Deepak Charan. Treatment Non-adherence Patterns Among Patients With Mental Illness: A Study From the District Mental Health Care Center in India. Cureus 2024; doi: 10.7759/cureus.54495
|
| 35 |
Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, Juan José Fernández-Miranda. Estudio en imagen en espejo (10 años de seguimiento y 10 de pretratamiento estándar) de ingresos hospitalarios de personas con esquizofrenia grave en un programa comunitario con gestión de casos. Revista de Psiquiatría y Salud Mental 2022; 15(1): 47 doi: 10.1016/j.rpsm.2019.04.004
|
| 36 |
Dulcinea Vega, Francisco J. Acosta, Pedro Saavedra. Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study. Comprehensive Psychiatry 2021; 108: 152240 doi: 10.1016/j.comppsych.2021.152240
|
| 37 |
Madeline Lim, Ziqiang Li, Huiting Xie, Bhing Leet Tan, Jimmy Lee. The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia. Journal of Clinical Psychopharmacology 2021; 41(5): 551 doi: 10.1097/JCP.0000000000001449
|
| 38 |
Mogammad Shaheed Soeker, Tamarin Truter, Nicole Van Wilgen, Polly Khumalo, Heather Smith, Simone Bezuidenhout. The experiences and perceptions of individuals diagnosed with schizophrenia regarding the challenges they experience to employment and coping strategies used in the open labor market in Cape Town, South Africa. Work 2019; 62(2): 221 doi: 10.3233/WOR-192857
|
| 39 |
Ghida Kassir, Samer El Hayek, Raghid Charara, Michele Cherro, Hala Itani, Joseph El Khoury, Abraham D. Flaxman. Predictors of admission to an assertive outreach service for psychosis in Lebanon. PLOS Global Public Health 2022; 2(12): e0001428 doi: 10.1371/journal.pgph.0001428
|
| 40 |
N. Yalcin-Siedentopf, F. Wartelsteiner, A. Kaufmann, F. Biedermann, M. Edlinger, G. Kemmler, M. A. Rettenbacher, C. G. Widschwendter, G. Zernig, W. W. Fleischhacker, A. Hofer. Measuring Adherence to Medication in Schizophrenia: The Relationship between Attitudes toward Drug Therapy and Plasma Levels of New-Generation Antipsychotics. International Journal of Neuropsychopharmacology 2015; 18(5): pyu091 doi: 10.1093/ijnp/pyu091
|
| 41 |
Meaghan Roach, Dee Lin, Marlon Graf, Priti Pednekar, Jacquelyn W Chou, Carmela Benson, Jalpa A Doshi. Schizophrenia population health management: perspectives of and lessons learned from population health decision makers. Journal of Managed Care & Specialty Pharmacy 2021; 27(10-a Suppl): S1 doi: 10.18553/jmcp.2021.27.10-a.s1
|
| 42 |
Giulia Cossu, Davide Gyppaz, Goce Kalcev, Anna Rafaela Manca, Matthias Angermeyer, Thurayya Zreik, Mauro G. Carta. Systematic review of involuntary hospitalisation and long-term compliance. International Review of Psychiatry 2023; 35(2): 209 doi: 10.1080/09540261.2022.2119074
|
| 43 |
Rama Melkote, Arun Singh, An Vermeulen, Bart Remmerie, Adam Savitz. Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. Schizophrenia Research 2018; 201: 324 doi: 10.1016/j.schres.2018.05.028
|
| 44 |
Yann Hode, Romain Padovani, Wydad Hikmat, Nathalie Guillard-Bouhet, Jérome Attal, Marie-Cecile Bralet, Mélanie Biotteau, Isabelle Chereau Boudet, Olivier Canceil, Aurélie Montagne Larmurier, Céline Roussel, Stéphanie Lemestré, Dominique Willard. Family psychoeducation in schizophrenia and schizophrenia related disorder, treatment compliance, and suicidal risk reduction: questions about their relationship from a naturalistic observation. Frontiers in Psychiatry 2024; 15 doi: 10.3389/fpsyt.2024.1370566
|
| 45 |
Tadele Eticha, Amha Teklu, Dagim Ali, Gebremedhin Solomon, Adissu Alemayehu, Jerson Laks. Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia. PLOS ONE 2015; 10(3): e0120560 doi: 10.1371/journal.pone.0120560
|
| 46 |
P.M. Ljungdalh. Non-adherence to pharmacological treatment in schizophrenia and schizophrenia spectrum disorders – An updated systematic literature review. The European Journal of Psychiatry 2017; 31(4): 172 doi: 10.1016/j.ejpsy.2017.08.001
|
| 47 |
Christy Lai-Ming Hui, Venessa Wing-Yan Poon, Vivian Shuk-Kuen Kwok, Wing-Chung Chang, Sherry Kit-Wa Chan, Edwin Ho-Ming Lee, Eric Yu-Hai Chen. Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosis. Psychiatry Research 2015; 228(3): 680 doi: 10.1016/j.psychres.2015.04.047
|
| 48 |
Warut Aunjitsakul, Teerapat Teetharatkul, Arnont Vitayanont, Tippawan Liabsuetrakul. Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?. Administration and Policy in Mental Health and Mental Health Services Research 2021; 48(5): 768 doi: 10.1007/s10488-021-01127-5
|
| 49 |
Päivi Soininen, Hanna Putkonen, Grigori Joffe, Jyrki Korkeila, Pauli Puukka, Anneli Pitkänen, Maritta Välimäki. Does experienced seclusion or restraint affect psychiatric patients’ subjective quality of life at discharge?. International Journal of Mental Health Systems 2013; 7(1) doi: 10.1186/1752-4458-7-28
|
| 50 |
Shi Hyun Kang, Hey Won Lee. Attitude Toward Illness and Treatment in Adherent Schizophrenia Patients: A Qualitative Study. Journal of Korean Neuropsychiatric Association 2020; 59(2): 159 doi: 10.4306/jknpa.2020.59.2.159
|
| 51 |
Rohan Mahabaleshwarkar, Dee Lin, Jesse Fishman, Todd Blair, Timothy Hetherington, Pooja Palmer, Charmi Patel, Carmela Benson, Kruti Joshi, Constance Krull, Oleg V. Tcheremissine. The Impact of Once-Monthly Paliperidone Palmitate on Healthcare Utilization Among Patients With Schizophrenia Treated in an Integrated Healthcare System: A Retrospective Mirror-Image Study. Advances in Therapy 2021; 38(4): 1958 doi: 10.1007/s12325-021-01626-9
|
| 52 |
Noraly Stam, Heidi Taipale, Antti Tanskanen, Luka Isphording, Cynthia Okhuijsen‐Pfeifer, Catharina C.M. Schuiling‐Veninga, Jens H.J. Bos, Bert J. Bijker, Jari Tiihonen, Jurjen J. Luykx. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics. Clinical and Translational Science 2020; 13(6): 1170 doi: 10.1111/cts.12801
|
| 53 |
Aikaterini Garbi, Ioannis Tiniakos, Zacharenia Mikelatou, Ioannis Drakatos. Decrease of Hospitalizations and Length of Hospital Stay in Patients with Schizophrenia Spectrum Disorders or Bipolar Disorder Treated in a Mobile Mental Health Service in Insular Greece. Psych 2021; 3(4): 780 doi: 10.3390/psych3040049
|
| 54 |
Shadi Aghamohammad, Asal Hafezi, Mahdi Rohani. Probiotics as functional foods: How probiotics can alleviate the symptoms of neurological disabilities. Biomedicine & Pharmacotherapy 2023; 163: 114816 doi: 10.1016/j.biopha.2023.114816
|
| 55 |
Andra Mihali, Marianne Broeker, Florian D. M. Ragalmuto, Guillermo Horga. Introspective inference counteracts perceptual distortion. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-42813-2
|
| 56 |
Marta Domínguez, Sara Sánchez‐Balcells, Regina Vila‐Badia, Esther Bergadà‐Sánchez, Miriam Vilaplana, Susana Ochoa, Maria Elena Huerta‐Ramos, Nuria Del Cacho, Judith Usall, Trini Peláez, Marta Coromina. Perspective of patients with first‐episode psychosis, their relatives, and mental health professionals on the design and usability of an app in clinical practice. Early Intervention in Psychiatry 2023; doi: 10.1111/eip.13468
|
| 57 |
Xiao-Qin Wang, Marcia Petrini, Donald E. Morisky. Comparison of the Quality of Life, Perceived Stigma and Medication Adherence of Chinese with Schizophrenia: A Follow-Up Study. Archives of Psychiatric Nursing 2016; 30(1): 41 doi: 10.1016/j.apnu.2015.10.006
|
| 58 |
Marwa A. El Meguid, Heba Eissawy, Walaa Sabry, Mostafa Bastawy, Doaa Khalifa, Ramy Ali. Understanding medication nonadherence in a sample of Egyptian patients with schizophrenia in relation to illness severity and insight. Middle East Current Psychiatry 2016; 23(4): 161 doi: 10.1097/01.XME.0000499561.13974.8c
|
| 59 |
Huan Hwa Chen, Hsin Tien Hsu, Pei Chao Lin, Chin-Yin Chen, Hsiu Fen Hsieh, Chih Hung Ko. Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial. JMIR Mental Health 2023; 10: e50806 doi: 10.2196/50806
|
| 60 |
Yumi Aoki, Hiroyoshi Takeuchi, Koichiro Watanabe, Allan Tasman. Tasman’s Psychiatry. 2023; : 1 doi: 10.1007/978-3-030-42825-9_132-1
|
| 61 |
Han Grezenko, Zarin Nudar Rodoshi, Ciara S Mimms, Muhammad Ahmed, Astrit Sabani, May Su Hlaing , Biniyam J Batu, Muhidin I Hundesa, Biruk D Ayalew, Abdullah Shehryar, Abdur Rehman, Ahmad Hassan. From Alzheimer’s Disease to Anxiety, Epilepsy to Schizophrenia: A Comprehensive Dive Into Neuro-Psychiatric Disorders. Cureus 2024; doi: 10.7759/cureus.58776
|
| 62 |
Tong Zhu. Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development—A Drug Developer's Perspective. Frontiers in Psychiatry 2021; 11 doi: 10.3389/fpsyt.2020.562660
|
| 63 |
Dulcinea Vega, Francisco J Acosta, Pedro Saavedra. Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study. World Journal of Psychiatry 2020; 10(11): 260-271 doi: 10.5498/wjp.v10.i11.260
|
| 64 |
Ludovic Samalin, Ingrid de Chazeron, Raoul Belzeaux, Pierre-Michel Llorca, Michel Botbol. Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patients. PLOS ONE 2017; 12(3): e0173267 doi: 10.1371/journal.pone.0173267
|
| 65 |
Felice Iasevoli, Andrea Fagiolini, Maria Vittoria Formato, Emiliano Prinzivalli, Sara Giordano, Raffaele Balletta, Vincenzo De Luca, Andrea de Bartolomeis. Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients. Psychiatry Research 2017; 249: 159 doi: 10.1016/j.psychres.2017.01.015
|
| 66 |
Karimah S. Bell Lynum, Ibrahim Turkoz, Edward Kim. Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia. Early Intervention in Psychiatry 2019; 13(3): 667 doi: 10.1111/eip.12685
|
| 67 |
Meng Ji, Wenxiu Xie, Mengdan Zhao, Xiaobo Qian, Chi-Yin Chow, Kam-Yiu Lam, Jun Yan, Tianyong Hao, Deepika Koundal. Probabilistic Prediction of Nonadherence to Psychiatric Disorder Medication from Mental Health Forum Data: Developing and Validating Bayesian Machine Learning Classifiers. Computational Intelligence and Neuroscience 2022; 2022: 1 doi: 10.1155/2022/6722321
|
| 68 |
Cordellia E. Bright. Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review. Archives of Psychiatric Nursing 2017; 31(1): 99 doi: 10.1016/j.apnu.2016.09.003
|
| 69 |
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Revista de Psiquiatría y Salud Mental (English Edition) 2017; 10(1): 4 doi: 10.1016/j.rpsmen.2016.09.002
|
| 70 |
Ramandeep Kaur, Ajeet Sidana, Nidhi Malhotra, Shikha Tyagi. Medication Adherence in Schizophrenia: Role of Opinion Makers. Indian Journal of Social Psychiatry 2023; 39(4): 388 doi: 10.4103/ijsp.ijsp_131_22
|
| 71 |
Amaury Lefebvre, Arnaud Pouchon, Stéphanie Bioulac, Jasmina Mallet, Mircea Polosan, Clément Dondé. Management of schizophrenia in women during the perinatal period: a synthesis of international recommendations. Expert Opinion on Pharmacotherapy 2022; 23(11): 1337 doi: 10.1080/14656566.2022.2102421
|
| 72 |
Saeed Farooq, Abid Choudry. Adherence to medication in the community: Audit cycle of interventions to improve the assessment of adherence. BJPsych Bulletin 2017; 41(1): 41 doi: 10.1192/pb.bp.115.053520
|
| 73 |
Pengxiang Li, Carmela Benson, Zhi Geng, Sanghyuk Seo, Charmi Patel, Jalpa A. Doshi. Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries With Schizophrenia. JAMA Network Open 2023; 6(9): e2334016 doi: 10.1001/jamanetworkopen.2023.34016
|
| 74 |
Zaina P. Qureshi, Rezaul Khandker, Jason Shepherd, Salome Samant, Farid Chekani, Hollie M. L. Bailey. Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance. Psychiatry Journal 2020; 2020: 1 doi: 10.1155/2020/5848601
|
| 75 |
Jalpa A. Doshi, Pengxiang Li, Zhi Geng, Sanghyuk Seo, Charmi Patel, Carmela Benson. Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia. Psychiatric Services 2024; 75(4): 333 doi: 10.1176/appi.ps.20230142
|
| 76 |
Yanling Zhou, Robert Rosenheck, Somaia Mohamed, Yuping Ning, Hongbo He. Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge. Psychiatry Research 2017; 250: 129 doi: 10.1016/j.psychres.2017.01.036
|
| 77 |
Marie Smith-East, Donna Felber Neff. Mental Health Care Access Using Geographic Information Systems: An Integrative Review. Issues in Mental Health Nursing 2020; 41(2): 113 doi: 10.1080/01612840.2019.1646363
|
| 78 |
Susanne Jaeger, Carmen Pfiffner, Prisca Weiser, Gerhard Längle, Daniela Croissant, Wiltrud Schepp, Reinhold Kilian, Thomas Becker, Gerhard Eschweiler, Tilman Steinert. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion. Social Psychiatry and Psychiatric Epidemiology 2013; 48(11): 1787 doi: 10.1007/s00127-013-0687-x
|
| 79 |
Yi Nam Suen, Emily Tsz Wa Yeung, Sherry Kit Wa Chan, Christy Lai Ming Hui, Edwin Ho Ming Lee, Wing Chung Chang, Candice Yu Hay Chan, Chan Eric Yu Hai Chen. Integration of biological and psychological illness attributional belief in association with medication adherence behaviour: A path analysis. Early Intervention in Psychiatry 2021; 15(6): 1686 doi: 10.1111/eip.13114
|
| 80 |
Isaac Tetteh Commey, Jerry Paul K. Ninnoni, Evelyn Asamoah Ampofo. Coping with personal care and stigma: experiences of persons living with schizophrenia. BMC Nursing 2022; 21(1) doi: 10.1186/s12912-022-00891-5
|
| 81 |
Carlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, An Vermeulen. A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds—Application to Simulated Risperidone Data in Schizophrenic Patients. The AAPS Journal 2019; 21(3) doi: 10.1208/s12248-019-0299-9
|
| 82 |
Oriana Bianchini, Stefano Porcelli, Claudia Nespeca, Dario Cannavò, Angela Trappoli, Eugenio Aguglia, Diana De Ronchi, Alessandro Serretti. Effects of antipsychotic drugs on insight in schizophrenia. Psychiatry Research 2014; 218(1-2): 20 doi: 10.1016/j.psychres.2014.03.022
|
| 83 |
Claire Ainsworth. Assessing the robustness of direct meta-analysis in the presence of heterogeneity. Journal of Comparative Effectiveness Research 2018; 7(10): 1009 doi: 10.2217/cer-2018-0024
|
| 84 |
Junpei Ishii, Fumitoshi Kodaka, Hisatsugu Miyata, Wataru Yamadera, Hikaru Seto, Hidejiro Higuchi, Yoshiaki Tsuruoka, Masahiro Shigeta. Association between functional recovery and medication adherence in schizophrenia. Neuropsychopharmacology Reports 2022; 42(4): 510 doi: 10.1002/npr2.12294
|
| 85 |
Yoon-A Choi, Young-Ran Kweon. Drug Attitude and Medication Adherence of Patients with Early Psychosis in South Korea: Mediating Effect of Medication Adherence Self-Efficacy. Patient Preference and Adherence 2023; : 1247 doi: 10.2147/PPA.S408781
|
| 86 |
Claudio Brasso, Marta Cisotto, Camilla Ghirardini, Filippo Pennazio, Vincenzo Villari, Paola Rocca. Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward. Psychiatry Research 2021; 305: 114214 doi: 10.1016/j.psychres.2021.114214
|
| 87 |
José Manuel Olivares, Andrea Fagiolini. Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.877867
|
| 88 |
Bunta Yoshimura, Kojiro Sato, Manabu Takaki, Norihito Yamada. Algorithm‐based pharmacotherapy for first‐episode schizophrenia involuntarily hospitalized: A retrospective analysis of real‐world practice. Early Intervention in Psychiatry 2019; 13(1): 39 doi: 10.1111/eip.12442
|
| 89 |
Charlotte Gary, Cécile Déal, Jennifer Boursicot‐Beuzelin, Bruno Falissard, Jean‐Yves Giordana, Eric Fakra, Ludovic Samalin, Sophie Bouju. Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross‐sectional OPTIMUS study. Pharmacoepidemiology and Drug Safety 2022; 31(3): 334 doi: 10.1002/pds.5397
|
| 90 |
Sofia Brissos, David Taylor. Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?. CNS Drugs 2022; 36(4): 315 doi: 10.1007/s40263-022-00906-4
|
| 91 |
Laura Deruyver, Clément Rigaut, Alejandro Gomez-Perez, Pierre Lambert, Benoit Haut, Jonathan Goole. In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery. International Journal of Nanomedicine 2023; : 1085 doi: 10.2147/IJN.S397650
|
| 92 |
Keh-Ming Lin, Mario Braakman, Kazutaka Shimoda, Norio Yasui-Furukori. Tasman’s Psychiatry. 2023; : 1 doi: 10.1007/978-3-030-42825-9_131-1
|
| 93 |
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking. Revista de Psiquiatría y Salud Mental 2017; 10(1): 4 doi: 10.1016/j.rpsm.2016.09.001
|
| 94 |
Sangeeta Tanna, Graham Lawson. Analytical Chemistry for Assessing Medication Adherence. 2016; : 87 doi: 10.1016/B978-0-12-805463-5.00004-3
|
| 95 |
David DeWorsop, Gina Creatura, Grai Bluez, Halle Thurnauer, Kimberlee Forselius-Bielen, Mohini Ranganathan, Emma Deaso, Jasra Ali Bhat, Deepak Cyril D’Souza. Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials. Drug and Alcohol Dependence 2016; 163: 24 doi: 10.1016/j.drugalcdep.2016.02.045
|
| 96 |
Slawomir Murawiec, Aleksandra Rajewska-Rager, Jerzy Samochowiec, Sylwia Kalinowska, Jacek Kurpisz, Joanna Krzyzanowska, Halina Sienkiewicz-Jarosz, Iwona Kurkowska-Jastrzebska, Agnieszka Samochowiec, Przemyslaw Bienkowski. Pharmacy switch of antipsychotic medications: patient’s perspective. Annals of General Psychiatry 2015; 14(1) doi: 10.1186/s12991-015-0066-y
|
| 97 |
Christian G. Widschwendter, Georg Kemmler, Maria A. Rettenbacher, Nursen Yalcin-Siedentopf, Alex Hofer. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication. BMC Psychiatry 2018; 18(1) doi: 10.1186/s12888-018-1791-y
|
| 98 |
Letícia P. Tergolina, Airton T. Stein, Evelise R. de Faria. Adherence to treatment in collective multiprofessional activities and factors associated with adherence in a specialized center for psychosocial care. Trends in Psychiatry and Psychotherapy 2020; 42(4): 329 doi: 10.1590/2237-6089-2019-0053
|
| 99 |
Luis Eduardo Jaramillo González, Carlos Gómez Restrepo, Jenny García Valencia, Ana María de la Hoz Bradford, Mauricio Ávila-Guerra, Adriana Bohórquez Peñaranda. Tratamiento con antipsicóticos de depósito del paciente adulto con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría 2014; 44: 40 doi: 10.1016/j.rcp.2015.05.005
|
| 100 |
Anirban Basu, Carmela Benson, Larry Alphs. Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia. Journal of Managed Care & Specialty Pharmacy 2018; 24(8): 759 doi: 10.18553/jmcp.2018.24.8.759
|
| 101 |
Stacy Ellenberg, Brandon A. Gaudiano. Behavior Therapy. 2022; : 505 doi: 10.1007/978-3-031-11677-3_22
|
| 102 |
Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima, Sakiko Yamada. Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan. Advances in Therapy 2020; 37(7): 3324 doi: 10.1007/s12325-020-01396-w
|
| 103 |
Alexander Keenan, Dee Lin, Jason Shepherd, Hollie Bailey, Carmela Benson, Sophie Meakin. Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey. BMC Psychiatry 2022; 22(1) doi: 10.1186/s12888-022-03846-x
|
| 104 |
S.M.Y. Arafat, B. Mali, H. Akter. Proportion and reasons for medication non-compliance among schizophrenics: A cross-sectional observation in a tertiary care hospital of Bangladesh. Asian Journal of Psychiatry 2018; 35: 52 doi: 10.1016/j.ajp.2018.05.005
|
| 105 |
David Fraguas, David Almenta Gallego, Sergio Arques-Egea, Marcos Gómez-Revuelta, Carlos Gómez Sánchez-Lafuente, Daniel Hernández Huerta, Daniel Núñez Arias, Beatriz Oda Plasencia-García, Carlos Parro Torres, Samuel Leopoldo Romero-Guillena, Elena Ros Cucurul, Cecilio Alamo. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. International Journal of Psychiatry in Clinical Practice 2023; 27(1): 82 doi: 10.1080/13651501.2022.2064308
|
| 106 |
Matt Shirley, Caroline M. Perry. Aripiprazole (ABILIFY MAINTENA®): A Review of Its Use as Maintenance Treatment for Adult Patients with Schizophrenia. Drugs 2014; 74(10): 1097 doi: 10.1007/s40265-014-0231-7
|
| 107 |
Chun Ting Chan, Swapna Verma, Mythily Subramaniam, Edimansyah Abdin, Jenny Tay. Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis—A Retrospective Mirror-Image Study. International Journal of Environmental Research and Public Health 2023; 20(4): 3403 doi: 10.3390/ijerph20043403
|
| 108 |
E. Chui, K.L. Wong, K.Y. Chan, M. Wong. Validation study of the Brief Medication Adherence Scale (BMAS) in patients with schizophrenia and related disorders in Hong Kong. Asian Journal of Psychiatry 2018; 37: 154 doi: 10.1016/j.ajp.2018.09.005
|
| 109 |
Nuray A Karanci, Aylin Aras, Guler Beril Kumpasoğlu, Demet Can, Ekin Çakır, Cemrenur Karaaslan, Mine Semerci, Duygu Tüzün. Living with schizophrenia: Perspectives of Turkish people with schizophrenia from two Patient Associations on how the illness affects their lives. International Journal of Social Psychiatry 2019; 65(2): 98 doi: 10.1177/0020764018820879
|
| 110 |
Hong Kyu Ihm, Sang Hoon Kim, Jung Ho Kim, Kang Su Ha, Hyun Park. Factors Related to Medication Adherence in Outpatients with Schizophrenia under More Than 5 Years of Treatment. Journal of Korean Neuropsychiatric Association 2016; 55(4): 397 doi: 10.4306/jknpa.2016.55.4.397
|
| 111 |
Frank E. Zongo, Jocelyne Moisan, Jean-Pierre Grégoire, Alain Lesage, Anara Richi Dossa, Sophie Lauzier. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia. Research in Social and Administrative Pharmacy 2018; 14(1): 53 doi: 10.1016/j.sapharm.2016.12.006
|
| 112 |
Andrea Aguglia, Laura Fusar-Poli, Antimo Natale, Andrea Amerio, Irene Espa, Veronica Villa, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D’Agostino, Gianluca Serafini, Mario Amore, Eugenio Aguglia, Giovanni Ostuzzi, Corrado Barbui. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study. Pharmacopsychiatry 2022; 55(06): 281 doi: 10.1055/a-1804-6211
|
| 113 |
Hsue‐Wei Chan, Chin‐Yu Huang, Wen‐Jui Feng, Yung‐Chieh Yen. Risperidone long‐acting injection and 1‐year rehospitalization rate of schizophrenia patients: A retrospective cohort study. Psychiatry and Clinical Neurosciences 2015; 69(8): 497 doi: 10.1111/pcn.12294
|
| 114 |
Subho Chakrabarti. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World Journal of Psychiatry 2014; 4(2): 30-36 doi: 10.5498/wjp.v4.i2.30
|
| 115 |
Lindsey Peters, Megan Dyer, Emily Schroeder, Manoranjan S. D’Souza. Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia. Journal of Pharmacy Technology 2023; 39(2): 88 doi: 10.1177/87551225231153541
|
| 116 |
Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Lee. One-Year Clinical Outcomes Following Electroconvulsive Therapy for Patients with Schizophrenia: A Nationwide Health Insurance Data-Based Study. Neuropsychiatric Disease and Treatment 2022; : 1645 doi: 10.2147/NDT.S373222
|
| 117 |
Sandra I. Ralat, Colin A. Depp, Guillermo Bernal. Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico: A Qualitative Study. Community Mental Health Journal 2018; 54(6): 707 doi: 10.1007/s10597-017-0202-z
|